Grady Burnett - Kaleido Biosciences Director
KLDODelisted Stock | USD 0.01 0.00 0.00% |
Director
Mr. Grady Burnett is Director of the Company. Mr. Burnett is CoFounder and General Partner at Bow Capital, an early stage VC firm he started in July 2016. Previously, he served as Chief Operating Officer of Flurry, Inc., a mobile analytics, monetization and advertising company. Mr. Burnett previously served as Vice President, Global Sales and Operations at Facebook, Inc., Director, North American Sales and Operations for Google, and Vice President, North American Sales, at DoubleClick. He serves on the Boards of East Palo Alto Tennis and Tutoring and Menlo School since 2018.
Tenure | 6 years |
Professional Marks | MBA |
Phone | 617 674 9000 |
Web | https://kaleido.com |
Kaleido Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.9993) % which means that it has lost $0.9993 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.8057) %, meaning that it created substantial loss on money invested by shareholders. Kaleido Biosciences' management efficiency ratios could be used to measure how well Kaleido Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 5.55 M in liabilities with Debt to Equity (D/E) ratio of 2.05, implying the company greatly relies on financing operations through barrowing. Kaleido Biosciences has a current ratio of 1.39, which is within standard range for the sector. Debt can assist Kaleido Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Kaleido Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kaleido Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kaleido to invest in growth at high rates of return. When we think about Kaleido Biosciences' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Kristina Cashman | Bassett Furniture Industries | 51 | |
Frank McGaughey | Haverty Furniture Companies | 63 | |
Vicki Palmer | Haverty Furniture Companies | 67 | |
George Henderson | Bassett Furniture Industries | 69 | |
Duncan Gage | LGI Homes | 68 | |
William Warden | Bassett Furniture Industries | 65 | |
John Belk | Bassett Furniture Industries | 58 | |
John Glover | Haverty Furniture Companies | 73 | |
John Alschuler | SL Green Realty | 72 | |
Frederick Schuermann | Haverty Furniture Companies | 72 | |
Barre Seibert | Tootsie Roll Industries | 79 | |
Arthur Schaier | Hanover Foods | 66 | |
Jennifer Carter | Hanover Foods | 44 | |
Allison Dukes | Haverty Furniture Companies | 43 | |
John Levy | SL Green Realty | 84 | |
Peter Brown | Bassett Furniture Industries | 72 | |
Walter McDowell | Bassett Furniture Industries | 63 | |
Thomas Hough | Haverty Furniture Companies | 63 | |
Lana LewisBrent | Tootsie Roll Industries | 74 | |
G Hough | Haverty Furniture Companies | 66 | |
Edward Lippy | Hanover Foods | 78 |
Management Performance
Return On Equity | -5.81 | ||||
Return On Asset | -1.0 |
Kaleido Biosciences Leadership Team
Elected by the shareholders, the Kaleido Biosciences' board of directors comprises two types of representatives: Kaleido Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kaleido. The board's role is to monitor Kaleido Biosciences' management team and ensure that shareholders' interests are well served. Kaleido Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kaleido Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Geoffrey Maltzahn, President Co-Founder | ||
Jeremy Buzzard, Senior Vice President - Corporate Development | ||
Johannes Vlieg, Chief Scientific Officer | ||
Grady Burnett, Director | ||
Mark Wingertzahn, VP Devel | ||
Bonnie Bassler, Director | ||
Jeffery Moore, Senior Vice President - Finance & Administration | ||
Clare Fisher, Chief Business Officer | ||
LLM JD, Chief Advisor | ||
Jerald Korn, General Counsel, Corporate Secretary | ||
Mike Bonney, Chairman of the Board, CEO | ||
John Sculley, Director | ||
Ruth ThieroffEkerdt, Chief Medical Officer | ||
Theo MelasKyriazi, Independent Director | ||
Kimberly Hocknell, VP Operations |
Kaleido Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Kaleido Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -5.81 | ||||
Return On Asset | -1.0 | ||||
Operating Margin | (79.28) % | ||||
Current Valuation | (16.73 M) | ||||
Shares Outstanding | 42.62 M | ||||
Shares Owned By Insiders | 0.73 % | ||||
Shares Owned By Institutions | 0.36 % | ||||
Number Of Shares Shorted | 2.34 M | ||||
Price To Earning | (1.45) X | ||||
Price To Book | 0 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Kaleido Pink Sheet
If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |